Oxytocin as an Anti-obesity Treatment
Obesity is a growing health concern, as it increases risk for heart disease, hypertension, type 2 diabetes, cancer, COVID-19 related hospitalizations and mortality. However, current weight loss therapies are often associated with psychiatric or cardiovascular side effects or poor tolerability that l...
Main Authors: | JingJing Niu, Jenny Tong, James E. Blevins |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.743546/full |
Similar Items
-
Effects of Combined Oxytocin and Beta-3 Receptor Agonist (CL 316243) Treatment on Body Weight and Adiposity in Male Diet-Induced Obese Rats
by: Melise M. Edwards, et al.
Published: (2021-09-01) -
Oxytocin Administration Alleviates Acute but Not Chronic Leptin Resistance of Diet-Induced Obese Mice
by: Mehdi Labyb, et al.
Published: (2018-12-01) -
Oxytocin: A Potential Therapeutic for Obesity
by: Soo Min Hong, et al.
Published: (2021-06-01) -
Oxytocin reduces adipose tissue inflammation in obese mice
by: Angela Szeto, et al.
Published: (2020-08-01) -
The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans
by: Liya Kerem, et al.
Published: (2021-07-01)